Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial.
The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis.
The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis. Biocell. 2022 May 18; 46(9):2003-2007.
View in:
PubMed
authors with profiles
Don C. Rockey
Zengdun Shi